Position in OGN
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$21,636
+$12,029 QoQ
Shares Held
1,598
-0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#318
of 626 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SALEM INVESTMENT COUNSELORS INC holds $225,886,114 across 15 Drug Manufacturers - General names. OGN ranks #14 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
78,924 | $94,663,821 | |
| 2 | JNJ |
Johnson & Johnson
|
176,284 | $44,770,847 | |
| 3 | ABBV |
AbbVie Inc.
|
132,322 | $33,297,508 | |
| 4 | MRK |
Merck & Co., Inc.
|
176,330 | $22,658,405 | |
| 5 | AMGN |
Amgen Inc
|
32,937 | $11,927,146 | |
| 6 | NVS |
Novartis AG
|
71,102 | $11,143,105 | |
| 7 | NVO |
Novo Nordisk A S
|
61,839 | $2,964,561 | |
| 8 | PFE |
Pfizer Inc
|
106,893 | $2,573,983 |
All Filings in OGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,636 | 1,598 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $9,607 | 1,604 | Shares | Sole | 2026-04-29 | |
| 2025-09-30 | $17,408 | 1,630 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $16,552 | 1,710 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $25,610 | 1,720 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $29,720 | 1,992 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $34,185 | 1,787 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $40,095 | 1,937 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $37,092 | 1,973 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $30,137 | 2,090 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $57,461 | 3,310 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $74,333 | 3,572 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $109,250 | 4,645 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $189,002 | 6,767 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $160,336 | 6,852 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $245,193 | 7,265 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $264,245 | 7,565 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $574,682 | 18,873 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $735,905 | 22,443 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $797,562 | 26,357 | Shares | Sole | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||